CANCER VACCINE INSTITUTE

Follow

Organization

London, GB

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Priming of cancer cells with low dose naltrexone
- Patent number 11,065,245
- Issue date Jul 20, 2021
- Cancer Vaccine Institute
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of cancer with naltrexone
- Patent number 9,895,438
- Issue date Feb 20, 2018
- Cancer Vaccine Institute
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE
- Publication number 20210308125
- Publication date Oct 7, 2021
- CANCER VACCINE INSTITUTE
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF CANCER WITH NALTREXONE
- Publication number 20180207263
- Publication date Jul 26, 2018
- CANCER VACCINE INSTITUTE
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE
- Publication number 20170119755
- Publication date May 4, 2017
- CANCER VACCINE INSTITUTE
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF CANCER WITH NALTREXONE
- Publication number 20160106832
- Publication date Apr 21, 2016
- CANCER VACCINE INSTITUTE
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks